Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

Real-time Quote. Real-time Tradegate - 07/01 01:38:04 pm
91.205 EUR   +0.17%
10:40a MERCK KGAA : Results of Pivotal TAILOR Study Confirm Addition of Erb..
08:10a MERCK KGAA : Successful Cooperation Between Merck and Agrimer in Mar..
06/28 MERCK KGAA : Expands Industry-Leading Emprove® Program to Include Fi..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Merck KGaA Gives Details On Planned Efficiency Program

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/24/2012 | 05:51pm CEST

-- Germany's Merck provides details about efficiency program.

-- Conglomerate joins a long list of drug makers revamping themselves.

-- Merck KGaA shares fall after restructuring update.

(Adds details, share details, background.)

   By Neetha Mahadevan 
   Of  
 

Pharmaceutical and chemical company Merck KGaA (>> Merck KGaA) said Friday it launched a cost-cutting and efficiency plan in the wake of increased price pressures in the U.S. and Europe and a series of drug development setbacks.

The company said the plan could involve job cuts across all businesses and regions to reduce costs and address "unprecedented market shifts", but it didn't disclose details, saying management still needed to speak with relevant stakeholders for a mutually acceptable solution.

"Over the next two years, Merck needs to address unprecedented market shifts, increasing competition in key product areas and existing inefficiencies in its own organization to ensure the long-term success of its business model," Chief Executive Karl-Ludwig Kley said in a statement.

With its new cost-cutting drive, the German chemical and pharmaceutical company joins a long list of other drug makers who are revamping themselves in response to falling sales and profitability.

The need to cut costs is partly due to mounting pressure stemming from health care reforms in the U.S. and Europe, where governments are increasingly reluctant to reimburse expensive drugs and advocate the use of cheaper generic medicines. Companies such as AstraZeneca Plc (AZ.LN), Novartis AG (NVS), Roche Holding AG (ROG.VX), Pfizer Inc (>> Pfizer Inc.), Eli Lilly & Co (>> Eli Lilly & Co.) have all embarked on cost saving or restructuring programs to keep costs under control.

In addition to set-backs in its drug pipeline, Merck has also been hit by a slowdown in demand at its chemicals division, which led to disappointing developments in the last year and prompted it to tighten its outlook time and again.

In the second-quarter, it recorded a 6.5% drop in revenue at its chemicals division, while in the third-quarter profits fell due largely to weakness in its performance materials division.

The efficiency measures are part of Merck's comprehensive transformation program, announced last year, and comprises two phases, the company said.

In the first two years, Merck plans to set up a new leadership organization, implement efficiency measures and focus on long-term growth, while the second phase will be focused on exploiting new growth opportunities, it added.

Merck KGaA shares fell after the news and at 1545 GMT traded down 1.2% at EUR79.70, while the DAX benchmark index traded 0.6% higher.

-By Neetha Mahadevan, Dow Jones Newswires; +49 69 2972 5507; neetha.mahadevan@dowjones.com

(Sten Stovall contributed to this article.)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on MERCK KGAA
10:40a MERCK KGAA : Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLF..
08:10a MERCK KGAA : Successful Cooperation Between Merck and Agrimer in Marine-Derived ..
06/28 MERCK KGAA : Expands Industry-Leading Emprove® Program to Include Filtration and..
06/28 EMD MILLIPORE : Verifi(Ab)le – Neuroscience Antibodies
06/28 MERCK KGAA : to Develop Next-Generation Purification Processes with Internationa..
06/25 MERCK : OBS Pakistan acquiring Merck Serono
06/24DJMERCK KGAA : Says It Has No Immediate Plans to Cut Jobs in UK
06/16 ASCO 2016 : Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel C..
06/16 MERCK KGAA : Men Having Babies' Gay Parenting Assistance Program Expanded to Hel..
06/16 MERCK KGAA : Epichem Successful in AusTrade Grant
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials